Clinical Trial Details

Overview

Research Study Summary

Study for adults with Hereditary Angioedema (HAE)

Purpose

Winthrop University Hospital Clinical Trials Center is seeking volunteers with inadequately controlled Hereditary Angioedema (HAE) for a clinical research study to test a medication already approved by the Food and Drug Administration (FDA) to investigate the safety and effectiveness of a higher dosage not approved by the FDA.

Patient Inclusion Criteria: Eligible participants will receive study-related medication and medical care at no cost to them. Compensation travel expenses may also be available. Inclusion criteria:

  • diagnosis of HAE with a documented history of swelling
  • have a history of an average of more than one HAE attack each month of any severity
  • must be receiving the recommended CINRYZE™ (c1 Esterase Inhibitor [Human]) dosing of 1000 U every three to four days via intravenous injection

Patient Exclusion Criteria:

  • N/A

To Learn more

CW ID: 165931
Date Last Changed: July 23, 2013

Clinical Trial Snapshot

Gender
Both Male and Female
Age
N/A
Overall Status
Recruiting
Facility Type
N/A

Contact

Study Nurse
Winthrop University Hospital Clinical Trials Center
222 Station Plaza North Suite 300
Mineola, NY 11501
Phone: 516-663-9582
Fax: 516-663-9587

View Map

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.